Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pflugers Arch ; 464(5): 459-70, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23007464

ABSTRACT

Zinc exists in biological systems as bound and histochemically reactive free Zn(2+) in the nanomolar range. Zinc is required as either structural or catalytic component for a large number of enzymes. It also modulates current passage through many ion channels. Here, we reinvestigated the effects of extracellular and intracellular Zn(2+) on the L-type Ca(2+) current (I (CaL)) and its modulation by ß-adrenergic stimulation in rat ventricular cardiomyocytes. In the absence of Ca(2+) ions, Zn(2+) could permeate through the L-type channel at much lower concentrations and at a more positive voltage range, but with a lower permeability than Ca(2+). In the presence of Ca(2+), extracellular Zn(2+) demonstrated strong bimodal inhibitory effects on the I (CaL), with half-inhibition occurring around 30 nM, i.e., in the range of concentrations found in the plasma. Intracellular Zn(2+) also significantly inhibited the I (CaL) with a half-inhibitory effect at 12.7 nM. Moreover, ß-adrenergic stimulation was markedly reduced by intracellular Zn(2+) at even lower concentrations (<1 nM) as a consequence of Zn(2+)-induced inhibition of the adenylyl cyclase. All these effects appeared independent of redox variations and were not affected by dithiothreitol. Thus, both basal intracellular and extracellular Zn(2+) modulate transmembrane Ca(2+) movements and their regulation by ß-adrenergic stimulation. Considering that, in many pathological situations, including diabetes, the extracellular Zn(2+) concentration is reduced and the intracellular one is increased, our results help to explain both Ca(2+) overload and marked reduction in the ß-adrenergic stimulation in these diseases.


Subject(s)
Calcium Channels, L-Type/physiology , Myocytes, Cardiac/physiology , Zinc/metabolism , Adrenergic beta-Agonists/pharmacology , Animals , Calcium/metabolism , Calcium Channels, L-Type/drug effects , Heart Diseases/metabolism , Heart Ventricles/cytology , Membrane Potentials/drug effects , Membrane Potentials/physiology , Rats , Zinc/pharmacology
2.
Curr Med Chem ; 19(31): 5414-23, 2012.
Article in English | MEDLINE | ID: mdl-22830340

ABSTRACT

Physalia physalis is a marine cnidarian from which high molecular weight toxins with hemolytic and neurotoxic effects have been isolated. In the present work, two novel toxins, PpV9.4 and PpV19.3 were purified from P. physalis by bioactive guideline isolation. It involved two steps of column chromatography, gel filtration and RP-HPLC. The molecular weights were 550.7 and 4720.9 Da for PpV9.4 and PpV19.3, respectively. In the light of the Edman sequencing results, the structure of these toxins included the presence of modified amino acids. Both toxins increased the percentage of insulin secreting beta-cells and induced cytosolic Ca2+ elevation. To date, this is the first report of low molecular weight toxins increasing insulin secretion purified from cnidarians, by constituting a new approach to the study of beta-cells physiology.


Subject(s)
Calcium/metabolism , Hydrozoa/metabolism , Insulin-Secreting Cells/drug effects , Insulin/metabolism , Toxins, Biological/pharmacology , Animals , Cell Survival/drug effects , Cells, Cultured , Chromatography, Gel , Chromatography, Reverse-Phase , Hemolysis/drug effects , Insulin Secretion , Insulin-Secreting Cells/metabolism , Rats , Rats, Wistar , Toxins, Biological/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...